Literature DB >> 7534360

Tetralogy of Fallot: diagnostic imaging after palliative and corrective surgery.

S B Greenberg1, E N Faerber, R K Balsara.   

Abstract

Tetralogy of Fallot was invariably fatal until the development of palliative and later corrective surgical procedures. The prognosis for children with tetralogy of Fallot continues to improve almost a half century after the earliest palliative surgical procedure was performed successfully. Imaging of the child and adult after surgery for tetralogy of Fallot remains an important challenge because surgical complications or limitations frequently require imaging for complete evaluation and further management of the patient. Traditional imaging by chest radiography and arteriography has been largely replaced by echocardiography and ultrafast and conventional CT, as well as magnetic resonance imaging. This article reviews those aspects of diagnostic imaging that are appropriate to study the postoperative chest in the child or adult with tetralogy of Fallot.

Entities:  

Mesh:

Year:  1995        PMID: 7534360

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  3 in total

Review 1.  Right ventricular function late after total repair of tetralogy of Fallot.

Authors:  Alexander van Straten; Hubert W Vliegen; Mark G Hazekamp; Albert de Roos
Journal:  Eur Radiol       Date:  2005-02-22       Impact factor: 5.315

2.  Diastolic dysfunction: a new additional criterion for optimal timing of pulmonary valve replacement in adult patient with tetralogy of Fallot?

Authors:  Barbara J M Mulder; Hubert W Vliegen; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-07-24       Impact factor: 2.357

3.  Role and effectiveness of cardiovascular magnetic resonance in the diagnosis, preoperative evaluation and follow-up of patients with congenital heart diseases.

Authors:  L Lovato; A Giardini; C La Palombara; V Russo; V Gostoli; G Gargiulo; F M Picchio; R Fattori
Journal:  Radiol Med       Date:  2007-07-23       Impact factor: 6.313

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.